|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
1451002 |
| 003 |
ICU |
| 005 |
19970809145400.0 |
| 008 |
930413s1993 enka b 001 0 eng c |
| 010 |
|
|
|a 92049585
|
| 020 |
|
|
|a 0412453304 (acid-free paper)
|
| 035 |
|
|
|a (ICU)BID16967989
|
| 035 |
|
|
|a (OCoLC)26636576
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC$dOrLoB
|
| 050 |
0 |
0 |
|a RC607.A26
|b M645 1993
|
| 060 |
|
|
|a WD 308 M718
|
| 082 |
|
|
|a 616.97/92
|2 20
|
| 245 |
0 |
0 |
|a Molecular and cell biology of opportunistic infections in AIDS /
|c edited by Steven Myint and Alan Cann.
|
| 250 |
|
|
|a 1st ed.
|
| 260 |
|
|
|a London ;
|a New York :
|b Chapman & Hall,
|c 1993.
|
| 300 |
|
|
|a xvi, 283 p. :
|b ill. ;
|c 25 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Molecular and cell biology of human diseases series
|v 2
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
2 |
0 |
|t Foreword /
|r David A. J. Tyrrell --
|g 1.
|t A clinical overview of opportunistic infections in patients with AIDS /
|r Martin J. Wiselka.
|g 1.2.
|t Clinical manifestations of opportunistic infections --
|g 2.
|t The application of molecular biology to the diagnosis of infectious disease /
|r Steven H. Myint.
|g 2.2.
|t Fundamentals.
|g 2.3.
|t Gene and probe amplification --
|g 3.
|t Salmonella, Shigella and Campylobacter /
|r Fran A. Rubin, Joanne L. Rhoads and Richard L. Warren.
|g 3.1.
|t The scope of the problem.
|g 3.2.
|t Mechanisms of pathogenesis.
|g 3.3.
|t Molecular approaches to diagnosis --
|g 4.
|t Mycobacteria /
|r Nicola T. Ralphs, Graham J. Boulnois and Peter W. Andrew.
|g 4.1.
|t Background.
|g 4.2.
|t Detection and identification of mycobacteria.
|g 4.3.
|t Epidemiology.
|g 4.4.
|t Manipulating mycobacteria.
|g 4.5.
|t Successful applications of molecular biology in mycobacteria.
|g 4.6.
|t The future --
|g 5.
|t Entamoeba histolytica /
|r William M. Spice, Jorge A. Cruz-Reyes and John P. Ackers.
|g 5.2.
|t Pathogenicity of amoebic infection.
|g 5.3.
|t Genetic organization.
|g 5.4.
|t Molecular pathogenesis.
|g 5.5.
|t Amoebiasis in AIDS.
|g 5.6.
|t Molecular diagnosis --
|g 6.
|t Cryptosporidium and Isospora /
|r Alain Bonnin, Eduardo Dei-Cas and Patrick Camerlynck.
|g 6.2.
|t Cryptosporidium.
|g 6.3.
|t Isospora --
|g 7.
|t Toxoplasma /
|r Demetris Savva.
|g 7.2.
|t Taxonomy and life cycle of Toxoplasma.
|g 7.3.
|t Antigenic and genomic organization of Toxoplasma.
|g 7.4.
|t Entry of Toxoplasma into the host.
|g 7.5.
|t Host-parasite interactions.
|g 7.6.
|t Toxoplasmosis in man.
|g 7.7.
|t Diagnosis of toxoplasmosis.
|g 7.8.
|t DNA probes.
|g 7.9.
|t Management of toxoplasmosis --
|g 8.
|t Pneumocystis carinii /
|r Julian M. Hopkin and Ann E. Wakefield.
|g 8.2.
|t Biochemistry.
|g 8.3.
|t Antigen studies.
|g 8.4.
|t DNA studies --
|g 9.
|t Candida /
|r Ruth Matthews.
|g 9.2.
|t Molecular biology, genetics and structure.
|g 9.3.
|t Pathogenesis and candidosis.
|g 9.4.
|t Epidemiology and typing methods.
|g 9.5.
|t Host defence against candidosis.
|g 9.6.
|t Serological tests for diagnosis.
|g 9.7.
|t Immunology of candidosis in AIDS.
|g 9.8.
|t The role of HSP 90 and autoantibodies --
|g 10.
|t Mycoplasmas and AIDS /
|r Shyh-Ching Lo, Hitoshi Kotani and S. Hu Wesni.
|g 10.2.
|t General biological properties of mycoplasmas.
|g 10.3.
|t Pathobiology of mycoplasmas.
|g 10.4.
|t Molecular biology of mycoplasmas.
|g 10.5.
|t AIDS-associated mycoplasmas --
|g 11.
|t Herpesviruses /
|r Vincent C. Emery, Alison Webster and Paul D. Griffiths.
|g 11.2.
|t Molecular structure and organization.
|g 11.3.
|t Gene expression and viral replication.
|g 11.4.
|t Molecular mechanisms of pathogenesis.
|g 11.5.
|t Herpesviruses as cofactors for HIV disease progression.
|g 11.6.
|t Molecular approaches to diagnosis.
|g 11.7.
|t Conclusions and future prospects --
|g 12.
|t Future prospects /
|r Steven H. Myint, Alan J. Cann and David A. J. Tyrrell.
|
| 650 |
|
0 |
|a AIDS (Disease)
|x Complications
|0 http://id.loc.gov/authorities/subjects/sh93006439
|
| 650 |
|
0 |
|a Opportunistic infections
|x Molecular aspects.
|
| 650 |
|
0 |
|a Opportunistic infections
|x Cytodiagnosis.
|
| 650 |
|
2 |
|a Acquired Immunodeficiency Syndrome
|x complications
|
| 650 |
|
2 |
|a Bacteria
|x pathogenicity
|
| 650 |
|
2 |
|a Bacterial Infections
|x complications
|
| 650 |
|
2 |
|a Opportunistic Infections
|x complications
|
| 650 |
|
7 |
|a AIDS (Disease)
|x Complications.
|2 fast
|0 http://id.worldcat.org/fast/fst00793817
|
| 700 |
1 |
0 |
|a Myint, Steven
|0 http://id.loc.gov/authorities/names/n92804789
|1 http://viaf.org/viaf/163050782
|
| 700 |
1 |
0 |
|a Cann, Alan
|0 http://id.loc.gov/authorities/names/n92804790
|1 http://viaf.org/viaf/49309831
|
| 850 |
|
|
|a ICU
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i f46482e5-97cd-50b5-8aa8-9672b63c1855
|s 13fe611d-06fd-5f91-9fac-aae26c5a914a
|
| 928 |
|
|
|t Library of Congress classification
|a RC607.A26M6450 1993
|l ASR
|c ASR-SciASR
|i 2548695
|
| 927 |
|
|
|t Library of Congress classification
|a RC607.A26M6450 1993
|l ASR
|c ASR-SciASR
|e CRERAR
|b 37382495
|i 2827951
|
